Inflammatory Bowel Disease Market Forecast

Introduction

The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor's updated forecast will parallel its previous forecast up to 2012, several new product launches, regional expansion and upgraded brand forecast will help to sustain growth in the second half of the forecast period.

Reasons to Purchase

• Understand how new brands Lialda and Apriso will fare against established market players, such as Asacol and Pentasa
• Assess the impact of the launch of Cimzia's recent pre-filled syringe and gauge future dynamics within the anti-TNF class
• Quantify the current and future size of the inflammatory bowel disease market